HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine

Immunology

Volumn 90, Issue 1, 1997, Pages 1-6

  Tsuji, T ^a   Fukushima, J ^a   Hamajima, K ^a   Ishii, N ^a   Aoki, I ^a   Bukawa, H ^a   Ishigatsubo, Y ^a   Tani, K ^a   Okubo, T ^a   Dorf, M E ^b   Okuda, K ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN G2A;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSTIMULATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; VACCINATION;

EID: 8044224656     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00117.x     Document Type: Article

References (37)

1. + cytotoxicity and natural killer cell activity in HIV infection. Immunology 74, 567.
2. CARMICHAEL A., JIN X., SISSONS P. & BORYSIEWICS L. (1993) Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 177, 249.
3. LANGLADE-DEMOYEN P., NGO-GIANG-HUONG N., FERCHAL F. & OKSENHENDLER E. (1994) HIV nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest 93, 1293.
4. ROWLAND-JONES S., SUTTON J., ARIYOSHI K. et al (1995) HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian woman. Nature Medicine 1, 59.
5. + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci USA 92, 2308.
6. + cell clones derived from HIV-infected and uninfected individuals. Cell Immunol 159, 271.
7. + cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeflcient mice from HIV-1 infection by an HLA-unrestricted mechanism. J Immunol 153, 4826.
8. CLERICI M., GIORGI J.V., CHOU C.-C. et al. (1992) Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV. J Infect Dis 165, 1012.
9. BUKAWA H., SEKIGAWA K., HAMAJIMA K. et al. (1995) Neutralization of HIV-1 by secretory IgA induced by oral immunization with a macromolecular multicomponent peptide vaccine candidate. Nature Med 1, 681.
10. BUKAWA H., FUKUSHIMA J., HAMAJIMA K. et al. (1995) Antibody responses raised against a conformational V3 loop peptide of HIV-1. Microbiol Immunol 39, 607.
11. OKUDA K. & KANEKO T. (1993) Strong synergistic effects of polyvalent vaccine using synthetic peptides for human immunodeficiency virus. AIDS Res Hum Retroviruses 9, 114.
12. OKUDA K., KANEKO T., YAMAKAWA T. et al. (1993) Strong synergistic effects of multicomponent vaccine for human immunodeficiency virus infection. J Clin Lab Immunol 40, 97.
13. OKUDA K., KANEKO T., YAMAKAWA T. et al. (1993) Strong immunogenicity of a multicomponent vaccine developed with the branched lysine oligopeptide (BLO) method for human immunodeficient virus-1 (HIV-1) infection. J Mol Recognit 6, 101.
14. OKUDA K., BUKAWA H., HAMAJIMA K. et al. (1995) Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV-1 env and rev gene products. AIDS Res Hum Retroviruses 11, 933.
15. LUO Y., LANING J., DEVI S., MAK J., SCHALL T.J. & DORF M.E. (1994) Biologic activities of the murine β-chemokine TCA3. J Immunology 153, 4616.
16. LANING J., KAWASAKI H., TANAKA E., LUO Y. & DORF M.E. (1994) Inhibition of in vivo tumor growth by the β chemokine, TCA3. J Immunol 153, 4625.
17. OKUDA K., TWINING S.S., DAVID C.S. & ATASSI M.Z. (1979) Genetic control of immune response to sperm whale myoglobin in mice. J Immunol 123, 182.
18. ZAGURY D., BERNARD J., CHEYNIER R. et al. (1988) A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS. Nature 332, 728.
19. ULMER J.B., DONNELLY J.J., PARKER S.E. et al. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745.
20. YOKOYAMA M., ZHANG J. & WHITTON J.L. (1995) DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J Virol 69, 2684.
21. XIANG Z.Q., SPITALNIK S., TRAN M., WUNNER W.H., CHENG J. & ERTL H.C. (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199, 132.
22. WANG B., UGEN K.E., SRIKANTAN V. et al. (1993) Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90, 4156.
23. GEISSLER E.K., WANG J., FECHNER J.H., BURLINGHAM J.W.J. & KNECHTLE S.J. (1994) Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle. J Immunol 152, 413.
24. TRINCHIERI G. (1994) Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84, 4008.
25. DEVI S., LANING J., LUO Y. & DORF M. E. (1995) Biologic activities of the β-chemokine TCA3 on neutrophils and macrophages. J Immunol 154, 5376.
26. COCCHI F., DEVICO A.L., GARZINO-DEMO A., ARYA S.K., GALLO R.C. & LUSSO P. (1995) Identificaion of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+T cells. Science 270, 1811.
27. ALKHATIB G., COMBADIERE C., BRODER C.C. et al (1996) CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955.
28. DENG H., LIU R., ELLMEIER W. et al. (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661.
29. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667.
30. CHOE H., FARZAN M., SUN Y. et al. (1996) The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85, 1135.
31. DORANZ B.J., RUCKER J., YI Y. et al. (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149.
32. MILLER M.D., WILSON S.D., DORF M.E., SEUANEZ H.N., O'BRIEN S.J. & KRANGEL M.S. (1990) Sequence and chromosomal location of the I-309 gene: relationship to genes encoding a family of inflammatory cytokines. J Immunol 145, 2737.
33. KOVACS J.A., BASELER M., DEWAR R.J. et al. (1995) Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. N Engl J Med 332, 567.
34. XIANO Z.Q., SPITALNIK S.L., CHENG J., ERIKSON J., WOJCZYK B. & ERTL H.C.J. (1995) Immune responses to nucleic acid vaccines to rabies virus. Virology 209, 569.
35. WOLFF J.A., MALONE R.W., WILLIAMS P. et al. (1990) Direct gene transfer into mouse muscle in vivo. Science 247, 1465.
36. WATANABE A., RAZ Z., KOHSAKA H. et al. (1993) Induction of antibodies to a kV region by gene immunization. J Immunol 151, 2871.
37. XIANG Z. & ERTL H.C.J. (1995) Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmid expressing cytokines. Immunity 2, 129.